Zobrazeno 1 - 10
of 509
pro vyhledávání: '"M Rienstra"'
Autor:
J E Siland, B Geelhoed, C Roselli, B Wang, H J Lin, S Weiss, S Trompet, M E van den Berg, E Z Soliman, L Y Chen, I Ford, J W Jukema, P W Macfarlane, J Kornej, H Lin, K L Lunetta, M Kavousi, J A Kors, M A Ikram, X Guo, J Yao, M Dörr, S B Felix, U Völker, N Sotoodehnia, D E Arking, B H Stricker, S R Heckbert, S A Lubitz, E J Benjamin, A Alonso, P T Ellinor, P van der Harst, M Rienstra
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0268768 (2022)
BackgroundBoth elevated and low resting heart rates are associated with atrial fibrillation (AF), suggesting a U-shaped relationship. However, evidence for a U-shaped causal association between genetically-determined resting heart rate and incident A
Externí odkaz:
https://doaj.org/article/ac9d5b0f7c084fa48d7e8ef72647886a
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246907 (2021)
AimsLimited causal evidence is available on the relationship between body mass index (BMI) and atrial fibrillation (AF) progression. Sex differences have been noted and may be relevant for AF progression. We investigated the association between the B
Externí odkaz:
https://doaj.org/article/703f201cc46c48d09cf7ec4ee2c5eba8
Autor:
Dhruva D. Dhavale, Alexander M. Barclay, Collin G. Borcik, Katherine Basore, Deborah A. Berthold, Isabelle R. Gordon, Jialu Liu, Moses H. Milchberg, Jennifer Y. O’Shea, Michael J. Rau, Zachary Smith, Soumyo Sen, Brock Summers, John Smith, Owen A. Warmuth, Richard J. Perrin, Joel S. Perlmutter, Qian Chen, James A. J. Fitzpatrick, Charles D. Schwieters, Emad Tajkhorshid, Chad M. Rienstra, Paul T. Kotzbauer
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. Here we develop and validate a method to amplify Asyn fibrils extracted from
Externí odkaz:
https://doaj.org/article/34678621ec164ec7a36f533a9c6f2b2a
Autor:
C Van Deutekom, B Geelhoed, B C Van Munster, S J L Bakker, R T Gansevoort, I C Van Gelder, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): The PREVEND study is supported by the Dutch Kidney Foundation and the Netherlands Heart Foundation. Background Atrial fibrillation (AF) is a condition that occurs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b51ec9297a8698609bf0a078eafbcdb
https://doi.org/10.1093/europace/euad122.038
https://doi.org/10.1093/europace/euad122.038
Autor:
E M Trinks-Roerdink, G J Geersing, C J Van Den Dries, F H Rutten, M E W Hemels, M Rienstra, M Van Smeden, D Van Klaveren, D M Kent, S Van Doorn
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Introduction Integrated care is effective in reducing all-cause mortality in patients with atrial fibrillation (AF) in primary care. Although this overall effect is undisputed, some individual p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::314bc0c259891c26450ed21c1b98fb88
https://doi.org/10.1093/europace/euad122.067
https://doi.org/10.1093/europace/euad122.067
Autor:
M H J Park Frausing, M Van De Lande, A H Maass, B O Nguyen, M E W Hemels, R Tieleman, T Koldenhof, M De Melis, D Linz, U Schotten, V Weberndorfer, H J G M Crijns, I C Van Gelder, J C Nielsen, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation, and grant support from M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62594651f11c7bc45779f9f33f4e9619
https://doi.org/10.1093/europace/euad122.221
https://doi.org/10.1093/europace/euad122.221
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Purpose To investigate whether there are differences between nondihydropyridine calcium channel blockers and beta blockers on heart rate in patients with paroxysmal and persistent atrial fibrill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c8d81b50d0b246055c1261ebfd5eae7
https://doi.org/10.1093/europace/euad122.073
https://doi.org/10.1093/europace/euad122.073
Autor:
M Lobeek, T M Gorter, V P M Van Empel, O C Manintveld, R G Tieleman, A H Maass, K Vernooy, B D Westenbrink, I C Van Gelder, D J Van Veldhuisen, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): unrestricted grant from Abbott-Netherlands to the University Medical Center Groningen Introduction Atrial fibrillation (AF) and heart failure (HF) with preserv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e8677528fd8d4a4b1deef69303605d
https://doi.org/10.1093/europace/euad122.003
https://doi.org/10.1093/europace/euad122.003
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Sudden cardiac death (SCD) is a leading cause of death. The implantable cardioverter-defibrillator (ICD) is an established therapy to prevent SCD in patients with prior ventricular ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c363e1adc7613a081346c1dda862bfd4
https://doi.org/10.1093/europace/euad122.413
https://doi.org/10.1093/europace/euad122.413
Autor:
M E Van De Lande, C Van Deutekom, B Geelhoed, L B O Nguyen, R G Tieleman, V Weberndorfer, H J G M Crijns, M E W Hemels, M De Melis, U Schotten, D Linz, I C Van Gelder, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): We acknowledge the support from the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1db42b0606b2935855311a539558136a
https://doi.org/10.1093/europace/euad122.027
https://doi.org/10.1093/europace/euad122.027